rejuvant life tabs

5 investment lessons from coronavirus

Latest articles

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...

Capsida Biotherapeutics emerges from stealth with $140m

Versant Ventures and Westlake Village BioPartners launch next-generation gene therapy company with $50m series A; AbbVie collaboration provides $90m for gene therapies for CNS...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...
Rejuvant

We are delighted to introduce our video-on-demand service: Longevity TV … initially we’re bringing you highlights from our recent conference.

Today we’re showcasing Sergey Young, the founder of the $100M Longevity Vision Fund, who joined us to reflect on investing in the Longevity sector, with particular reference to the lessons we can learn from the current COVID-19 pandemic.

Opening with the sober thought that some cities in the world have the same mortality risks from COVID-19 as climbing Mount Everest, Young goes on explain that what is different about the current situation and the lessons we can learn from it can be both summed up by one word: TECHNOLOGY.

“It’s really rewarding for me as a human being,” Young tells us, “To see an enormous degree of collaboration: governments helping governments; people and volunteers helping people; car makers and luxury goods producers repurposing their production lines to support and fight with the outbreak; former enemies, like Big Pharma, or former competitors are joining forces to fast-track R&D.”

Sergey highlights three companies that are demonstrating how important AI technology is in battling COVID-19:

Elevant
  • Bluedot – predicting and modeling disease outbreak early
  • inferVISION – detecting COVID-19 in CT scans in just 20 seconds
  • Benevolent AI – finding potential drugs in weeks, rather than months

“A call for action – we finally need to recognise aging as a disease…”


 

Sergey’s reflections on the current COVID crisis:

Lesson 1 – big data analytics for data prediction – Young reveals which company first “joined the dots” and predicted the coronavirus outbreak and just why we should love AI.
Lesson 2 – rapid genome sequencing of the virus – find out why synthetic copies are important and what is pushing R&D acceleration.
Lesson 3 – accelerated development of COVID diagnostics – why is the current testing landscape unique?
Lesson 4 – biotech & AI focus on drug and vaccine solutions – repurposing and vaccines.
Lesson 5 – novel methods for disease and quarantine management – robots, algorithms, QR codes and drones!

Elevant

Sergey Young draws on his lessons to show how important technology has been and how it brings not only investment opportunities, but the chance to make a change to the current situation. He calls this his “Investment Takeaways” and discusses in the video how we should recognise the Turning Point and Success Factors and reveals three key investable areas:

  • Drug and vaccine development
  • AI in medicine
  • Digital health

Watch more presentations from Lynne Cox, Aubrey de Grey, Nir Barzilai and Greg Bailey, among others here

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

FOXO exclusively licenses epigenetic clocks from UCLA

FOXO Technologies' exclusive licence of epigenetic clocks PhenoAge and GrimAge from UCLA could be an insurance game-changer. FOXO Technologies Inc has announced the licence of...

K4Connect selected for national tech accelerator

Aging in place start-up K4Connect has been selected for the National Association of Realtors’ 2021 Tech Accelerator. North Carolina start-up K4Connect is behind the K4Community solution,...

Exclusive interview with Alex Zhavoronkov

Insilico CEO on spreading the longevity message – the time is now. Dr Alex Zhavoronkov is the CEO and co-founder of Insilico Medicine, a pioneering AI...

The Sheekey Science Show – Senolytics

This new senescence biomarker may help evaluate senolytic efficacy. Senescent cells, also known as "zombie cells", accumulate with age. There are many different ways in...
Supps report ad middle